IWP-2; 686770-61-6; IWP 2; Wnt Inhibitor IWP-2; N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide; IWP-2 (GMP); CHEMBL1257064; N-(6-methylbenzo[d]thiazol-2-yl)-2-((4-oxo-3-phenyl-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)acetamide; F0579-0037; C22H18N4O2S3; N-(6-Methylbenzo[d]thiazol-2-yl)-2-(4-oxo-3-phenyl-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-ylthio)acetamide; CID 2155128; IWP2; N-(6-methyl-1,3-benzothiazol-2-yl)-2-[(4-oxo-3-phenyl-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)sulfanyl]acetamide; inhibitor of Wnt Production-2; SCHEMBL12571758; DTXSID50366724; CHEBI:125649; HMS3652J22; BCP09534; EX-A2264; ZINC2719689; BDBM50428028; HB0344; HY-13912G; MFCD04457599; NSC753606; s7085; AKOS024457669; CCG-208106; CS-1578; NSC-753606; SB19436; IWP-2, >=98% (HPLC); NCGC00347948-01; NCGC00347948-11; AC-32858; AS-55819; HY-13912; N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]; CS-0626098; EU-0088954; FT-0670578; SW066807-3; J3.628.165K; A12707; AB00668695-01; BRD-K82924899-001-01-9; Q27216260; N -(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2- d ]pyrimidin-2-yl)thio]-acetamide; N -(6-Methyl-2-benzothiazolyl)-2-[(3a?4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2- d ]pyrimaidin-2-yl)thio]-acetamide; N-(6-methyl-1,3-benzothiazol-2-yl)-2-[(4-oxo-3-phenyl-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)thio]acetamide; N-(6-Methyl-2-benzothiazolyl)-2-[(3 ,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide